Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about NASDAQ:IMUX
Recent news which mentions NASDAQ:IMUX
Immunic Inc. CEO Daniel Vitt Highlights Advances in MS Treatment on World MS Day
May 30, 2024
Tags
NASDAQ:IMUX
From
News Direct
Immunic CMO discusses role of clinical trials in biotech development for Clinical Trials Day
May 20, 2024
Tickers
IMUX
Tags
NASDAQ:IMUX
From
News Direct
Immunic chief medical officer discusses promising treatments to mark World IBD Day
May 17, 2024
Tickers
IMUX
Tags
NASDAQ:IMUX
From
News Direct
Immunic highlights IMU-856 gastrointestinal candidate to mark International Celiac Day
May 16, 2024
Tickers
IMUX
Tags
NASDAQ:IMUX
From
News Direct
Immunic CEO Dr Daniel Vitt discusses key Q1 advances and upcoming milestones
May 09, 2024
Tickers
IMUX
Tags
NASDAQ:IMUX
From
News Direct
IMUX Stock Earnings: Immunic Misses EPS for Q1 2024
May 08, 2024
Tickers
IMUX
Tags
NASDAQ:IMUX
Market News
Earnings Reports
From
InvestorPlace
Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal
May 01, 2024
Tickers
IMUX
Tags
NASDAQ:IMUX
From
News Direct
Immunic CEO Dr Daniel Vitt marks International Day of Immunology with discussion on its crucial role
April 29, 2024
Tags
NASDAQ:IMUX
From
News Direct
Immunic CMO discusses complexities of multiple sclerosis to mark MS Awareness Month
March 21, 2024
Tickers
IMUX
Tags
NASDAQ:IMUX
From
News Direct
Immunic secures key patent, boosting MS drug exclusivity and global IP strategy
March 21, 2024
Tags
NASDAQ:IMUX
From
News Direct
Immunic to reveal promising MS treatment data in two poster presentations at ACTRIMS Forum 2024
March 08, 2024
Tags
NASDAQ:IMUX
From
News Direct
Immunic reports successful 2023 and prepares for key 2025 milestones
February 22, 2024
Tags
NASDAQ:IMUX
From
News Direct
Immunic focusing on business development during Q4
November 14, 2023
Tags
NASDAQ:IMUX
From
News Direct
Immunic CSO hails "great" progress with MS program
October 24, 2023
Tickers
IMUX
Tags
NASDAQ:IMUX
From
News Direct
Immunic "super excited" about latest PMS trial data
October 11, 2023
Tickers
IMUX
Tags
NASDAQ:IMUX
From
News Direct
Immunic CEO hails "great day" after completing IMU-838 phase 2 trial enrolment
August 21, 2023
Tickers
IMUX
Tags
NASDAQ:IMUX
From
News Direct
Immunic CEO says Q2 results "couldn't be better"
August 07, 2023
Tickers
IMUX
Tags
NASDAQ:IMUX
From
News Direct
Immunic Inc eyeing "big step" for multiple sclerosis patients
July 25, 2023
Tickers
IMUX
Tags
NASDAQ:IMUX
From
News Direct
Immunic Therapeutics shares IMU-856 mode of action and target for gastrointestinal diseases
June 26, 2023
Tags
NASDAQ:IMUX
From
News Direct
Immunic ultimately hoping to "offer patients a new kind of treatment" for multiple sclerosis
May 31, 2023
Tags
NASDAQ:IMUX
From
News Direct
Immunic says preclinical data for vidofludimus calcium is a milestone for its lead MS program
May 17, 2023
Tags
NASDAQ:IMUX
From
News Direct
Immunic Inc set to bring relief with encouraging results
May 16, 2023
Tickers
IMUX
Tags
NASDAQ:IMUX
From
News Direct
Immunic IMU-856 trial data "clearly goes beyond" initial expectations
May 04, 2023
Tickers
IMUX
Tags
NASDAQ:IMUX
From
News Direct
Immunic gets a "positive surprise" from lead asset trial
April 13, 2023
Tickers
IMUX
Tags
NASDAQ:IMUX
From
News Direct
2 Biotech Stocks to Take off Your Watchlist in 2022
October 19, 2022
Tags
NASDAQ:IMUX
:DNA
From
StockNews.com
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.